Cellebrite (CLBT) CIO Shavit Sigalit discloses initial share and option positions

Rhea-AI Filing Summary

Cellebrite DI Ltd. executive Shavit Sigalit, the Chief Information Officer, reported her initial ownership position. She holds 82,738 Ordinary Shares directly, including time-based RSUs and performance share units that vest between May 2026 and February 2030, subject to service and performance conditions. She also holds stock options for 31,421 Ordinary Shares at an exercise price of $12.73 per share, expiring in August 2034, with a portion already vested and additional tranches vesting quarterly through August 2028.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Shavit Sigalit

Role Chief Information Officer

Type	Security	Shares	Price	Value
holding	Stock options	--	--	--
holding	Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	--	--	--

Holdings After Transaction: Stock options — 31,421 shares (Direct); Ordinary shares, par value NIS 0.00001 ("Ordinary Shares") — 82,738 shares (Direct)

Footnotes (1)

1. Includes 19,560 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on August 8, 2024, of which 1,956 vest on each of May 8, 2026 and every three months thereafter through August 8, 2028. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Includes 3,132 Ordinary Shares that are represented by RSUs that were granted on February 11, 2025, of which 261 vest on each of May 11, 2026 and every three months thereafter through February 11, 2029. Includes 11,740 Ordinary Shares that are represented by performance share units ("PSUs") that were granted on August 8, 2024, and vest based on the Issuer meeting certain total shareholder return thresholds for 60 consecutive trading days through August 8, 2028. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon vesting and settlement. Includes 31,593 Ordinary Shares that are represented by RSUs that were granted on February 10, 2026 and vest as follows: 7,905 vest on the one year anniversary of the grant date and 1,974 vest every three months thereafter through February 10, 2030. Of these stock options, 11,791 are fully vested and exercisable and 1,963 vest on each of May 8, 2026 and every three months thereafter through August 8, 2028.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Shavit Sigalit

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	82,738(1)(2)(3)(4)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock options	(5)	08/08/2034	Ordinary Shares	31,421	$12.73	D

Explanation of Responses:

1. Includes 19,560 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on August 8, 2024, of which 1,956 vest on each of May 8, 2026 and every three months thereafter through August 8, 2028. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

2. Includes 3,132 Ordinary Shares that are represented by RSUs that were granted on February 11, 2025, of which 261 vest on each of May 11, 2026 and every three months thereafter through February 11, 2029.

3. Includes 11,740 Ordinary Shares that are represented by performance share units ("PSUs") that were granted on August 8, 2024, and vest based on the Issuer meeting certain total shareholder return thresholds for 60 consecutive trading days through August 8, 2028. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon vesting and settlement.

4. Includes 31,593 Ordinary Shares that are represented by RSUs that were granted on February 10, 2026 and vest as follows: 7,905 vest on the one year anniversary of the grant date and 1,974 vest every three months thereafter through February 10, 2030.

5. Of these stock options, 11,791 are fully vested and exercisable and 1,963 vest on each of May 8, 2026 and every three months thereafter through August 8, 2028.

	/s/ Sigalit Shavit	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 filing show about Cellebrite (CLBT) CIO Shavit Sigalit?

The Form 3 shows Chief Information Officer Shavit Sigalit’s initial ownership in Cellebrite, including Ordinary Shares, restricted share units, performance share units, and stock options with detailed vesting schedules extending through 2030 and an option expiration in August 2034.

How many Cellebrite (CLBT) Ordinary Shares does Shavit Sigalit report owning?

She reports direct ownership of 82,738 Ordinary Shares. This total includes time-based restricted share units and performance share units that convert into shares only upon meeting service-based and total shareholder return performance conditions over several years.

What equity awards are included in Shavit Sigalit’s Cellebrite (CLBT) share holdings?

Her holdings include RSUs granted in August 2024, February 2025, and February 2026, plus PSUs granted in August 2024. These awards vest quarterly or annually from May 2026 through February 2030, with PSUs tied to total shareholder return thresholds through August 2028.

What stock options does Shavit Sigalit hold in Cellebrite (CLBT)?

She holds stock options over 31,421 Ordinary Shares at an exercise price of $12.73 per share, expiring on August 8, 2034. Of these, 11,791 options are already vested, with additional tranches vesting quarterly starting May 8, 2026 through August 8, 2028.

Are Shavit Sigalit’s Cellebrite (CLBT) equity awards fully vested today?

No. A portion of her stock options is fully vested, but many RSUs, PSUs, and remaining options vest over time. Vesting runs from May 2026 to February 2030, with PSUs depending on total shareholder return performance through August 8, 2028.

Does the Cellebrite (CLBT) Form 3 show any recent insider buying or selling by Shavit Sigalit?

The Form 3 does not report any recent purchases or sales. It is an initial ownership filing that lists her existing Ordinary Shares, unvested RSUs, PSUs, and outstanding stock options, without indicating any new market transactions.